These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 795576)
1. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease. Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction. Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447 [TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures. Górski AJ; Dupont B; Hansen JA; Good RA J Immunol; 1976 Sep; 117(3):865-70. PubMed ID: 134123 [TBL] [Abstract][Full Text] [Related]
4. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency. Hahn T; Levin S; Handzel ZT Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010 [TBL] [Abstract][Full Text] [Related]
5. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro. Górski AJ; Dupont B; Hansen JA; Good RA Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141 [TBL] [Abstract][Full Text] [Related]
6. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657 [TBL] [Abstract][Full Text] [Related]
7. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test. Miyagawa Y; Kawasaki A; Komiyama A; Akabane T Microbiol Immunol; 1978; 22(11):701-10. PubMed ID: 370507 [TBL] [Abstract][Full Text] [Related]
8. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay. van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334 [TBL] [Abstract][Full Text] [Related]
9. [Immunoprofile of LMIF in immunologic deficiency syndromes. I. Lymphocytes suppressing lymphokines in mixed lymphocyte culture]. Górski A Pol Arch Med Wewn; 1978 Apr; 59(4):389-93. PubMed ID: 149302 [No Abstract] [Full Text] [Related]
10. Use of transfer factor in patients with depressed cellular immunity and chronic infection. Rocklin RE Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987 [TBL] [Abstract][Full Text] [Related]
11. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components. Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte unresponsiveness to mitogens in vitro is not equivalent with severe immunodeficiency. Platz P; Faber V; Hedeskov CJ; Morling N; Ryder LP; Svejgaard A; Thomsen M; Thyme S; Valerius NH Birth Defects Orig Artic Ser; 1978; 14(6A):131-6. PubMed ID: 728553 [No Abstract] [Full Text] [Related]
13. The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor. Li J; Yousefi S; Sterling M; Carandang G; Vaziri N; Pahl M; Cesario T J Clin Lab Immunol; 1987 Jan; 22(1):13-7. PubMed ID: 3104595 [TBL] [Abstract][Full Text] [Related]
14. Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen. Schuurman RK; Gelfand EW; Dosch HM J Immunol; 1980 Aug; 125(2):820-6. PubMed ID: 6967091 [TBL] [Abstract][Full Text] [Related]
15. [Immunoprofile of LMIF in immunologic deficiency syndromes. II. Mediator production by isolated subpopulations of human lymphocytes]. Górski A Pol Arch Med Wewn; 1978 Apr; 59(4):395-401. PubMed ID: 149303 [No Abstract] [Full Text] [Related]
16. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
17. Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. Twomey JJ; Waddell CC; Krantz S; O'reilly R; L'esperance P; Good RA J Lab Clin Med; 1975 Jun; 85(6):968-77. PubMed ID: 124324 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients. Crivii SM; Crişan M; Crişan M Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694 [TBL] [Abstract][Full Text] [Related]
19. Leucocyte migration inhibitory factor assay in Nigerians with urinary schistosomiasis. Arinola OG; Salimonu LS West Afr J Med; 1999; 18(2):101-5. PubMed ID: 10504865 [TBL] [Abstract][Full Text] [Related]
20. Treatment of combined immunodeficiency with thymic extract (Thymostimulin). Lin CY; Hsu HC; Chen CL; Shen EY Ann Allergy; 1987 May; 58(5):379-84. PubMed ID: 3578932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]